MEGAN WORTHINGTON: Open Payments
NPI 1770369308 · LOUISVILLE, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 19 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $54 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $70 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $59 |
| Axsome Therapeutics, Inc. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $38 |
| Esperion Therapeutics, Inc. | 2 | $31 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $21 |
| ARGENX US, INC. | 1 | $21 |
| ABBVIE INC. | 1 | $18 |
| Exact Sciences Corporation | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $17 |
Products named: JARDIANCE, Auvelity, Wegovy, Kerendia, NEXLETOL, Ozempic, ISTURISA, VYVGART HYTRULO.
Industry payments across KY — which companies pay providers there.
